BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 16735935)

  • 1. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
    Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.
    Panay N; Al-Azzawi F; Bouchard C; Davis SR; Eden J; Lodhi I; Rees M; Rodenberg CA; Rymer J; Schwenkhagen A; Sturdee DW
    Climacteric; 2010 Apr; 13(2):121-31. PubMed ID: 20166859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
    Buster JE; Kingsberg SA; Aguirre O; Brown C; Breaux JG; Buch A; Rodenberg CA; Wekselman K; Casson P
    Obstet Gynecol; 2005 May; 105(5 Pt 1):944-52. PubMed ID: 15863529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone for low libido in postmenopausal women not taking estrogen.
    Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
    N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
    El-Hage G; Eden JA; Manga RZ
    Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder.
    Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Cianci A
    Urology; 2004 May; 63(5):955-9. PubMed ID: 15134988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
    Barton DL; Wender DB; Sloan JA; Dalton RJ; Balcueva EP; Atherton PJ; Bernath AM; DeKrey WL; Larson T; Bearden JD; Carpenter PC; Loprinzi CL
    J Natl Cancer Inst; 2007 May; 99(9):672-9. PubMed ID: 17470735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.
    Davis SR; Goldstat R; Papalia MA; Shah S; Kulkarni J; Donath S; Bell RJ
    Menopause; 2006; 13(1):37-45. PubMed ID: 16607097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone patch: new drug. Don't use to stimulate women's sexual desire.
    Prescrire Int; 2007 Oct; 16(91):190-2. PubMed ID: 17926827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen.
    Nachtigall L; Casson P; Lucas J; Schofield V; Melson C; Simon JA
    Gynecol Endocrinol; 2011 Jan; 27(1):39-48. PubMed ID: 21142609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg S
    J Sex Med; 2007 Mar; 4 Suppl 3():227-34. PubMed ID: 17394595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
    Shifren JL; Braunstein GD; Simon JA; Casson PR; Buster JE; Redmond GP; Burki RE; Ginsburg ES; Rosen RC; Leiblum SR; Caramelli KE; Mazer NA
    N Engl J Med; 2000 Sep; 343(10):682-8. PubMed ID: 10974131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy for sexual dysfunction in postmenopausal women.
    Hubayter Z; Simon JA
    Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoactive sexual desire disorder in postmenopausal women.
    Nappi RE; Wawra K; Schmitt S
    Gynecol Endocrinol; 2006 Jun; 22(6):318-23. PubMed ID: 16785156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.